Rigel Pharmaceuticals (RIGL)

03:31 AM

Rigel Pharmaceuticals: 3-Drug Company Reaches Profitability (RIGL) - Seeking Alpha

03:31 AM

08:05 AM

Rigel Strengthens Biotech Team: Strategic Stock Grants Attract Key Talent - Stock Titan

08:05 AM

07:10 AM

High Growth Tech Stocks in the US for April 2025 - simplywall.st

07:10 AM

Apr 02, 2025

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Not Doing Enough For Some Investors As Its Shares Slump 26% - simplywall.st

Apr 02, 2025

Mar 27, 2025

Rigel settles patent litigation regarding its immune thrombocytopenia treatment - MSN

Mar 27, 2025

Mar 27, 2025

Rigel settles patent litigation over TAVALISSE treatment By Investing.com - Investing.com South Africa

Mar 27, 2025

Mar 27, 2025

Rigel Pharma stock rises on patent settlement (RIGL:NASDAQ) - Seeking Alpha

Mar 27, 2025

Mar 27, 2025

Rigel, Hetero Settle Patent Suit Over Platelet-Booster Tavalisse - Bloomberg Law News

Mar 27, 2025

Mar 27, 2025

Rigel climbs on blood disorder drug patent settlement - TradingView

Mar 27, 2025

Mar 27, 2025

Rigel settles patent litigation regarding its immune thrombocytopenia treatment (RIGL:NASDAQ) - Seeking Alpha

Mar 27, 2025

Mar 27, 2025

Rigel Pharma Settles Tavalisse Patent Litigation With Annora Pharma - Nasdaq

Mar 27, 2025

Mar 27, 2025

Rigel Pharmaceuticals Settles Patent Litigation Over Tavalisse - MarketScreener

Mar 27, 2025

Mar 27, 2025

Rigel Pharmaceuticals resolves patent litigation related to Tavalisse - TipRanks

Mar 27, 2025

Mar 27, 2025

Rigel Announces Settlement Agreement Resolving TAVALISSE® (Fostamatinib Disodium Hexahydrate) Patent Litigation - Marketscreener.com

Mar 27, 2025

Mar 27, 2025

Rigel settles patent litigation over TAVALISSE treatment - Investing.com

Mar 27, 2025

Mar 27, 2025

Rigel Announces Settlement Agreement Resolving TAVALISSE® (fostamatinib disodium hexahydrate) Patent Litigation - PR Newswire

Mar 27, 2025

Mar 27, 2025

Rigel Wins Patent Battle: TAVALISSE Exclusivity Protected Until 2032 in Major Settlement - Stock Titan

Mar 27, 2025

Mar 25, 2025

(RIGL) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Mar 25, 2025

Mar 25, 2025

Bristol-Myers Squibb expands immuno-oncology pipeline with Flexus Biosciences, Rigel Pharmaceuticals deals - FirstWord Pharma

Mar 25, 2025

Mar 21, 2025

Rigel Pharmaceuticals appoints Mark W. Frohlich to board of directors - MSN

Mar 21, 2025

Mar 15, 2025

Statutory Profit Doesn't Reflect How Good Rigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are - Yahoo Finance

Mar 15, 2025

Mar 15, 2025

(RIGL) Investment Analysis and Advice - news.stocktradersdaily.com

Mar 15, 2025

Mar 13, 2025

Rigel Pharmaceuticals’ SWOT analysis: pipeline potential drives stock outlook - Investing.com India

Mar 13, 2025

Mar 13, 2025

Rigel Pharmaceuticals’ SWOT analysis: pipeline potential drives stock outlook By Investing.com - Investing.com South Africa

Mar 13, 2025

Mar 11, 2025

Rigel Looks Interesting, But Let's Wait For A Lower Price (NASDAQ:RIGL) - Seeking Alpha

Mar 11, 2025

Mar 10, 2025

Rigel Pharmaceuticals appoints new board member By Investing.com - Investing.com Australia

Mar 10, 2025

Mar 10, 2025

Rigel Pharmaceuticals adds oncology expert to board By Investing.com - Investing.com Australia

Mar 10, 2025

Mar 10, 2025

SEC Form 4 filed by Director Frohlich Mark W - Quantisnow

Mar 10, 2025

Mar 10, 2025

Rigel Pharmaceuticals appoints new board member - Investing.com

Mar 10, 2025

Mar 10, 2025

Rigel Pharmaceuticals Inc. filed SEC Form 8-K: Leadership Update - Quantisnow

Mar 10, 2025

Mar 10, 2025

Rigel Pharmaceuticals Appoints Dr. Frohlich to Board - TipRanks

Mar 10, 2025

Mar 10, 2025

Rigel appoints Mark W. Frohlich to its board -March 10, 2025 at 12:01 pm EDT - Marketscreener.com

Mar 10, 2025

Mar 10, 2025

Rigel Pharmaceuticals adds oncology expert to board - Investing.com India

Mar 10, 2025

Mar 10, 2025

Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors - StockTitan

Mar 10, 2025

Mar 09, 2025

Rhumbline Advisers Has $423,000 Stock Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) - Defense World

Mar 09, 2025

Mar 08, 2025

FY2025 EPS Estimates for RIGL Increased by Cantor Fitzgerald - Defense World

Mar 08, 2025

Mar 08, 2025

Citigroup Forecasts Strong Price Appreciation for Rigel Pharmaceuticals (NASDAQ:RIGL) Stock - Defense World

Mar 08, 2025

Mar 08, 2025

Rigel Pharmaceuticals Implements 1-for-10 Reverse Stock Split: Balancing Nasdaq Compliance and Investor Appeal - MSN

Mar 08, 2025

Mar 08, 2025

Rigel Pharmaceuticals (NASDAQ:RIGL) Downgraded by StockNews.com to “Buy” - Defense World

Mar 08, 2025

Mar 08, 2025

What is B. Riley’s Forecast for RIGL Q1 Earnings? - Defense World

Mar 08, 2025

Mar 08, 2025

What is HC Wainwright’s Estimate for RIGL Q1 Earnings? - Defense World

Mar 08, 2025

Mar 07, 2025

Earnings call transcript: Rigel Pharmaceuticals Q4 2024 sees strong growth By Investing.com - Investing.com Australia

Mar 07, 2025

Mar 07, 2025

Rigel Pharmaceuticals, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance

Mar 07, 2025

Mar 07, 2025

Rigel Pharmaceuticals, Inc. to Host Earnings Call - ACCESS Newswire

Mar 07, 2025

Mar 07, 2025

B. Riley Forecasts Strong Price Appreciation for Rigel Pharmaceuticals (NASDAQ:RIGL) Stock - Defense World

Mar 07, 2025

Mar 07, 2025

HC Wainwright Reiterates Buy Rating for Rigel Pharmaceuticals (NASDAQ:RIGL) - Defense World

Mar 07, 2025

Mar 07, 2025

What is B. Riley’s Estimate for RIGL FY2026 Earnings? - Defense World

Mar 07, 2025

Mar 07, 2025

Q3 Earnings Forecast for RIGL Issued By HC Wainwright - Defense World

Mar 07, 2025

Mar 06, 2025

Rigel Pharmaceuticals price target raised to $55 from $49 at Citi - TipRanks

Mar 06, 2025

Mar 06, 2025

Citi lifts Rigel stock price target to $55, maintains Buy rating - Investing.com

Mar 06, 2025